Incyte Corp. (INCY): Price and Financial Metrics

Incyte Corp. (INCY): $52.82

0.10 (+0.19%)

POWR Rating

Component Grades








Add INCY to Watchlist
Sign Up

Industry: Biotech




#4 of 362

in industry

INCY Price/Volume Stats

Current price $52.82 52-week high $75.74
Prev. close $52.72 52-week low $50.27
Day low $52.26 Volume 1,830,300
Day high $53.15 Avg. volume 1,710,365
50-day MA $57.56 Dividend yield N/A
200-day MA $59.49 Market Cap 11.86B

INCY Stock Price Chart Interactive Chart >

Incyte Corp. (INCY) Company Bio

ncyte is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, and Morges, Switzerland. The company was created in 2002 through the merger of Incyte Pharmaceuticals, founded in Palo Alto, California in 1991 and Incyte Genomics, Inc. of Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. (Source:Wikipedia)

INCY Latest News Stream

Event/Time News Detail
Loading, please wait...

INCY Latest Social Stream

Loading social stream, please wait...

View Full INCY Social Stream

Latest INCY News From Around the Web

Below are the latest news stories about INCYTE CORP that investors may wish to consider to help them evaluate INCY as an investment opportunity.

12 Most Promising Gene Editing Stocks According to Hedge Funds

In this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds. If you want to skip our take on how the gene editing industry sits right at the top of the global innovation food chain, then you can take a look at the 5 Most Promising […]

Yahoo | December 20, 2023

13 Most Promising Healthcare Stocks According to Analysts

In this article, we discuss the 13 most promising healthcare stocks according to analysts. To skip the detailed overview of the healthcare sector, go directly to the 5 Most Promising Healthcare Stocks According to Analysts. The healthcare industry landscape is changing. While the COVID-19 pandemic was one of the most significant events that led to […]

Yahoo | December 19, 2023

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

John Blankenhorn on InvestorPlace | December 16, 2023

The 3 Most Undervalued Biotech Stocks to Buy in December

Biotech is an increasing area of interest in the financial markets, line your portfolio up with these winning biotech stocks.

Gabriel Osorio-Mazzilli on InvestorPlace | December 15, 2023

Incyte Stock Is the S&P 500’s Top Performer. Here’s Why It’s Surging.

Shares of biopharmaceutical company Incyte were on track Tuesday for their best trading session in more than six years. The stock rose 8.6% to $61.97 on Tuesday, putting Incyte shares on pace for their largest increase since Aug. 30, 2017, when they gained 11%, according to Dow Jones Market Data. It was the top performer in the on Tuesday.

Yahoo | December 12, 2023

Read More 'INCY' Stories Here

INCY Price Returns

1-mo -9.31%
3-mo -14.10%
6-mo -4.19%
1-year -28.48%
3-year -37.54%
5-year -28.58%
YTD -15.88%
2023 -21.83%
2022 9.43%
2021 -15.61%
2020 -0.39%
2019 37.32%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!